The identification of ESR1, NRP2, AXL, ERBB2, and GAB1 as key genes provides novel therapeutic targets and highlights the importance of understanding shared molecular pathways in osteoporosis and sarcopenia. This evidence concerns the gene ESR1 and osteoporosis.